about
Era of direct acting antivirals in chronic hepatitis C: Who will benefit?Cardiac imaging approaches to evaluate drug-induced myocardial dysfunctionAnagrelide-induced cardiomyopathy.Vascular events associated with alpha interferon therapy.Interferon-α increases monocyte migration via platelet-monocyte interaction in murine intestinal microvessels.Cardiotoxicity of cancer therapy.Interferon related pericarditis: Review.Interferon in the Treatment of Multiple Myeloma.Elevated plasma levels of N-terminal pro-brain natriuretic peptide in patients with chronic hepatitis C during interferon-based antiviral therapyCardiac and cardiovascular toxicity of nonanthracycline anticancer drugs.Single-dose pharmacokinetics and tolerability of pegylated interferon-alpha2b in young and elderly healthy subjects.Antiviral therapy: current concepts and practicesAutoimmunity in picornavirus infections.Interferon-α and pericardial injury: a case report and literature review.Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart diseaseRecurrent Pericarditis, an Unexpected Effect of Adjuvant Interferon Chemotherapy for Malignant Melanoma.Risk of vascular disease in patients with multiple sclerosis: a review.Cancer chemotherapy and cardiac arrhythmias: a review.Effect of Chronic Hepatitis C Virus Treatment by Combination Therapy on Cardiovascular System.Cardiovascular Toxicities Associated with Cancer Immunotherapies.The role of alpha-interferon in essential thrombocythaemia, polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): a concise update.Reversible cardiomyopathy in a patient with hairy cell leukaemia.Is combination therapy for chronic hepatitis C toxic for cardiac function?Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin.Adverse Events in Cancer Immunotherapy.Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy.Exosomal biomarkers in Down syndrome and Alzheimer's disease.Fênomeno de Raynaud grave associado a terapia com interferon-beta para esclerose múltipla: relato de caso
P2860
Q26777506-10F6BEA8-6BB8-43A6-8F7F-3B3EFCC61F67Q30446453-8E501294-FB7E-47D1-B36D-902A311DD147Q31463097-D4F7C288-38C0-4E00-8008-702E1D1AE91BQ33347441-3E6AE22B-15F8-41E5-9288-460B74F872D4Q33390973-1F6A9095-4D87-4231-B613-BE1F8C06F7DBQ33704056-7C022437-D1D9-42BC-922D-FCE1BC3392E3Q33854144-2181E05B-8B4A-4A8F-8AED-E2211B588A2AQ33889240-B465409C-3478-444B-8020-DF4B340A7587Q33909833-CAA6C0DB-0CDC-426F-9566-5BCAB25E78ECQ34571555-08319E77-A31B-4DD8-A48B-6078729C3BDDQ35825645-9A0F2CF0-3D30-4F50-AE38-4A8FC7F239BFQ36070394-E7694221-45D7-4659-8C6A-B0FDB4AFF7DAQ36767670-2C8E0B2E-A9CE-4102-8D77-6BB81BD6CCBAQ36800951-241628F9-C4FE-44E4-B05F-9C2BD0B31780Q36824521-2174CF7A-DB2F-48B0-BE9D-96B59FFCFF97Q37067527-EE3DBEA1-C57F-424C-848D-35D0D8A51724Q38019658-FC9680DB-0026-4F20-9EC2-D53789E4ADE9Q38313870-A8A6A759-B36C-4331-9865-9AE66EF1BB11Q38909432-3BCC7F9B-EA0D-4E17-B41A-0AB98F71A01EQ39144916-C3DA9F94-FCD7-4BEE-843E-AD3D673826C5Q40953190-9B0D2092-2A56-4466-8E38-CFCAE76B5028Q41834091-1CE8BC45-1447-41F4-AF96-E2BFE5220AD7Q42129945-DBFC2DAA-1441-4894-B99A-57EB80EE9295Q42285332-E8C65A54-2226-4D98-B683-403C6038BBD4Q46764956-AE9A6FFE-72F4-4417-9CE7-CEB32CDBC2BCQ46884498-30DF3738-10DB-4570-A1CF-B9DF2C58F338Q47681122-3DDDBC32-5ECC-41D1-ADBA-088D96B4F172Q47960190-2EF4514A-5ACC-4D4E-A51C-5CD0ECC762C0Q57381831-663231DE-7AF1-4285-BDC2-4D5AC09C908F
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Cardiotoxicity of interferon. A review of 44 cases.
@ast
Cardiotoxicity of interferon. A review of 44 cases.
@en
type
label
Cardiotoxicity of interferon. A review of 44 cases.
@ast
Cardiotoxicity of interferon. A review of 44 cases.
@en
prefLabel
Cardiotoxicity of interferon. A review of 44 cases.
@ast
Cardiotoxicity of interferon. A review of 44 cases.
@en
P356
P1433
P1476
Cardiotoxicity of interferon. A review of 44 cases.
@en
P2093
Sonnenblick M
P304
P356
10.1378/CHEST.99.3.557
P407
P577
1991-03-01T00:00:00Z